Sigthor Sigmarsson

Sigthor (C.Sc. electronic engineering) brings a broad skillset to the table with experience from finance and private equity, as well as from the telecom, pharmaceutical and IT industries.

Andreas Herrmann

Andreas (PhD, biochemistry) has over 2 decades of experience from the pharmaceutical industry, both as a member of top management in multinational companies and as an entrepreneur in biopharmaceutical innovation.

Sigurgeir Guðlaugsson

Sigurgeir (B.Sc. international business) has an impressive track record from the pharmaceutical industry, having been CEO of a biotechnology company, global head of M&A at Actavis Group and managing director of the healthcare arm of an international investment firm.

Örn Viðar Skúlason

Örn (Industrial engineer, MSc. In corporate finance) has an extensive experience from management of companies in the banking and marine industries. He represents New Business Venture Fund on the board of 3Z.

Hlynur Stefánsson

Will soon be announced.


Our board of directors is comprised of experienced people from different fields. Their backgrounds include pharmaceuticals, engineering, computer science and finance; all of which are essential facets to successfully running a pharmaceutical company driven by software innovation.